ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases

F Cappuzzo; C Calandri; S Bartolini; L Crinò

doi:10.1038/sj.bjc.6601116

ZD 1839 in patients with brain metastases from non-small-cell lung cancer (NSCLC): report of four cases

Br J Cancer. 2003 Jul 21;89(2):246-7. doi: 10.1038/sj.bjc.6601116.

Authors

F Cappuzzo¹, C Calandri, S Bartolini, L Crinò

Affiliation

¹ Division of Medical Oncology, Bellaria Hospital, Via Altura 3, 40139 Bologna, Italy. [email protected]

Abstract

The activity of ZD 1839 on brain metastases (BM) from Non-Small-Cell Lung Cancer (NSCLC) is unknown. We report four cases of BM responding to ZD 1839 theraphy.

Publication types

Case Reports

MeSH terms

Aged
Antineoplastic Agents / pharmacology*
Brain Neoplasms / drug therapy*
Brain Neoplasms / radiotherapy
Brain Neoplasms / secondary*
Carcinoma, Non-Small-Cell Lung / drug therapy*
Carcinoma, Non-Small-Cell Lung / radiotherapy
Carcinoma, Non-Small-Cell Lung / secondary*
Female
Gefitinib
Humans
Lung Neoplasms / pathology*
Male
Middle Aged
Quinazolines / pharmacology*
Tomography, X-Ray Computed
Treatment Outcome

Substances

Antineoplastic Agents
Quinazolines
Gefitinib